Bioaffinity Technologies Inc.

This study is testing a new, non-invasive test called FlowPath Lung that analyzes a person's sputum (mucus coughed up from the lungs) to see if it can accurately detect early-stage lung cancer. It is for people at high risk for lung cancer who already have a small lung nodule fou…